BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  W. James Hindman Wins 2018 International Heart-repreneur® of the Year Award

  W. James “Jim” Hindman, founder of Jiffy Lube International and the Hindman Foundation, has been recognized by Heartrepreneur LLC.

  February 19, 2018

   · 

  2 min read
• Business

  Biocom Appoints Four New Members to Its Board

  Biocom, the association representing the California life science industry, today announced the appointment of four new members to its board.

  February 19, 2018

   · 

  2 min read
• 2018 LifeSciences BC Annual Award Winners Announced

  LifeSciences BC is pleased to announce the recipients of the 20th Annual LifeSciences BC Awards.

  February 19, 2018

   · 

  3 min read
• Deals

  DanDrit Biotech Announces Completion Of The Acquisition Of Enochian

  DanDrit Biotech USA, Inc. announced the completion of its previously reported acquisition of Enochian Biopharma Inc.

  February 19, 2018

   · 

  2 min read
• 

  FDA

  FDA Makes Changes to Alzheimer’s Clinical Trial Goals Amidst Recent Failures

  Despite the recent dismal news regarding Alzheimer’s drug development, the U.S. Food and Drug Administration (FDA) recently proposed new guidelines for developing drugs for the disease.

  February 19, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Analysts Split Over Buffett’s Backing of Teva Pharma

  Some analysts are scratching their head over Warren Buffet’s investment in Teva Pharma.

  February 19, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  3 Biotech Stocks That Soared Recently

  Three biotech stocks gained over 25 percent last week.

  February 19, 2018

   · 

  2 min read

   · 

  Mark Terry
• 3 Top Biotech Stocks to Consider in February

  Analysts with The Motley Fool looked at three biotech stocks that even biotech-leery investors might consider.

  February 19, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Eli Lilly and Hanmi Shutter a Failed Phase II RA Trial

  Eli Lilly and its Korean collaborative partner Hanmi stopped a Phase II trial on an experimental rheumatoid arthritis treatment following less-than-stellar interim results.

  February 19, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Novartis Could Put Sandoz U.S. Generic Pills Business on the Auction Block Within a Few Weeks

  Novartis may soon be looking to sell off its generics subsidiary Sandoz.

  February 19, 2018

   · 

  2 min read

   · 

  Alex Keown